Imugene Limited Set To Trial Bird Flu Vaccines

Biotechnology company Imugene Ltd is about to trial two potential avian influenza vaccines on chickens to see if they protect the fowls from the potentially fatal illness. The challenge trials follow laboratory development of the candidate vaccines to fight the H5N1 virus, after the company started developing the technology at its facilities at La Trobe University.

Back to news